Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase

Outstanding results have been obtained in the treatment of chronic myeloid leukemia (CML) with first-line imatinib therapy. However, approximately 35% of patients will not obtain long-term benefit with this approach. Allogeneic hematopoietic stem cell transplantation (HCT) is a valuable second- and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood
Hlavní autoři: Pavlů, Jiří, Kew, Andrea K., Taylor-Roberts, Beatrice, Auner, Holger W., Marin, David, Olavarria, Eduardo, Kanfer, Edward J., MacDonald, Donald H., Milojkovic, Dragana, Rahemtulla, Amin, Rezvani, Katayoun, Goldman, John M., Apperley, Jane F., Szydlo, Richard M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2010
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143151/
https://ncbi.nlm.nih.gov/pubmed/20304808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-01-263624
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky